Why Injection Site Matters for GLP-1 Drugs
GLP-1 medications like semaglutide and tirzepatide are designed for subcutaneous injection. That means the medication goes into the fat layer just under the skin, not into muscle. The subcutaneous layer absorbs the drug slowly and predictably, which is exactly what these medications need to work properly.
When the needle reaches muscle tissue instead, absorption speeds up in ways that make the medication less effective and more likely to cause side effects. Muscle has a richer blood supply than fat, so anything injected there enters the bloodstream faster than intended. This changes the drug's behavior and can lead to unpredictable results.
Choosing the Right Injection Location
Three body areas are approved for GLP-1 injections: the upper arm, the thigh, and the abdomen. Each one has a thick enough fat layer for most people, but they are not all equal in terms of consistency.
The abdomen tends to offer the most reliable absorption because the subcutaneous fat layer is generally thick and uniform across the area. The upper arm works well if you have enough fat there, though reaching the right spot without help can be tricky. The thigh is a solid option, particularly for self-injections, since you have full control over the angle and depth.
Subcutaneous fat thickness varies from person to person and even from one body part to another on the same person. A healthcare provider can help you figure out which area works best for your body type.
